Skip to main content

Doxil News

Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin

TUESDAY, Sept. 19, 2023 – For female survivors of childhood cancer, the risk for subsequent breast cancer (SBC) is more than twofold higher for those who receive a cumulative dose of 200 mg/m² or ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Ovarian Cancer, Multiple Myeloma

Doxil patient information at Drugs.com